- Home
- SEER vs STHO Comparison
SEER vs STHO Comparison
Compare SEER & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- STHO
- Stock Information
- Founded
- SEER 2017
- STHO N/A
- Country
- SEER United States
- STHO United States
- Employees
- SEER N/A
- STHO N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- STHO Real Estate
- Sector
- SEER Health Care
- STHO Real Estate
- Exchange
- SEER Nasdaq
- STHO Nasdaq
- Market Cap
- SEER 143.3M
- STHO 153.3M
- IPO Year
- SEER 2020
- STHO N/A
- Fundamental
- Price
- SEER $2.36
- STHO $10.20
- Analyst Decision
- SEER Hold
- STHO
- Analyst Count
- SEER 1
- STHO 0
- Target Price
- SEER $3.00
- STHO N/A
- AVG Volume (30 Days)
- SEER 214.1K
- STHO 57.5K
- Earning Date
- SEER 11-06-2024
- STHO 11-05-2024
- Dividend Yield
- SEER N/A
- STHO N/A
- EPS Growth
- SEER N/A
- STHO N/A
- EPS
- SEER N/A
- STHO 6.15
- Revenue
- SEER $14,608,000.00
- STHO $117,752,000.00
- Revenue This Year
- SEER N/A
- STHO N/A
- Revenue Next Year
- SEER $34.78
- STHO N/A
- P/E Ratio
- SEER N/A
- STHO $1.68
- Revenue Growth
- SEER N/A
- STHO 13.35
- 52 Week Low
- SEER $1.51
- STHO $10.06
- 52 Week High
- SEER $2.63
- STHO $15.31
- Technical
- Relative Strength Index (RSI)
- SEER 48.61
- STHO 22.50
- Support Level
- SEER $2.41
- STHO $10.06
- Resistance Level
- SEER $2.52
- STHO $10.47
- Average True Range (ATR)
- SEER 0.12
- STHO 0.29
- MACD
- SEER -0.03
- STHO -0.03
- Stochastic Oscillator
- SEER 15.87
- STHO 5.76
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. It focuses on realizing value for shareholders from the legacy portfolio by maximizing cash flows through active asset management and asset sales.